The synergistic effect of Canady Helios cold atmospheric plasma and a FOLFIRINOX regimen for the treatment of cholangiocarcinoma in vitro
Abstract Cholangiocarcinoma (CCA) is a rare biliary tract cancer with a low five-year survival rate and high recurrence rate after surgical resection. Currently treatment approaches include systemic chemotherapeutics such as FOLFIRINOX, a chemotherapy regimen is a possible treatment for severe CCA c...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2021-04-01
|
| Series: | Scientific Reports |
| Online Access: | https://doi.org/10.1038/s41598-021-88451-w |
| _version_ | 1818845863059914752 |
|---|---|
| author | Olivia Jones Xiaoqian Cheng Saravana R. K. Murthy Lawan Ly Taisen Zhuang Giacomo Basadonna Michael Keidar Jerome Canady |
| author_facet | Olivia Jones Xiaoqian Cheng Saravana R. K. Murthy Lawan Ly Taisen Zhuang Giacomo Basadonna Michael Keidar Jerome Canady |
| author_sort | Olivia Jones |
| collection | DOAJ |
| description | Abstract Cholangiocarcinoma (CCA) is a rare biliary tract cancer with a low five-year survival rate and high recurrence rate after surgical resection. Currently treatment approaches include systemic chemotherapeutics such as FOLFIRINOX, a chemotherapy regimen is a possible treatment for severe CCA cases. A limitation of this chemotherapy regimen is its toxicity to patients and adverse events. There exists a need for therapies to alleviate the toxicity of a FOLFIRINOX regimen while enhancing or not altering its anticancer properties. Cold atmospheric plasma (CAP) is a technology with a promising future as a selective cancer treatment. It is critical to know the potential interactions between CAP and adjuvant chemotherapeutics. In this study the aim is to characterize the efficacy of FOLFIRINOX and CAP in combination to understand potential synergetic effect on CCA cells. FOLFIRINOX treatment alone at the highest dose tested (53.8 µM fluorouracil, 13.7 µM Leucovorin, 5.1 µM Irinotecan, and 3.7 µM Oxaliplatin) reduced CCA cell viability to below 20% while CAP treatment alone for 7 min reduced viability to 3% (p < 0.05). An analysis of cell viability, proliferation, and cell cycle demonstrated that CAP in combination with FOLFIRINOX is more effective than either treatment alone at a lower FOLFIRINOX dose of 6.7 µM fluorouracil, 1.7 µM leucovorin, 0.6 µM irinotecan, and 0.5 µM oxaliplatin and a shorter CAP treatment of 1, 3, or 5 min. In conclusion, CAP has the potential to reduce the toxicity burden of FOLFIRINOX and warrants further investigation as an adjuvant therapy. |
| first_indexed | 2024-12-19T05:36:25Z |
| format | Article |
| id | doaj.art-9e5a2b2479b94b92ad0a587c178b6017 |
| institution | Directory Open Access Journal |
| issn | 2045-2322 |
| language | English |
| last_indexed | 2024-12-19T05:36:25Z |
| publishDate | 2021-04-01 |
| publisher | Nature Portfolio |
| record_format | Article |
| series | Scientific Reports |
| spelling | doaj.art-9e5a2b2479b94b92ad0a587c178b60172022-12-21T20:34:08ZengNature PortfolioScientific Reports2045-23222021-04-0111111110.1038/s41598-021-88451-wThe synergistic effect of Canady Helios cold atmospheric plasma and a FOLFIRINOX regimen for the treatment of cholangiocarcinoma in vitroOlivia Jones0Xiaoqian Cheng1Saravana R. K. Murthy2Lawan Ly3Taisen Zhuang4Giacomo Basadonna5Michael Keidar6Jerome Canady7Jerome Canady Research Institute for Advanced Biological and Technological SciencesJerome Canady Research Institute for Advanced Biological and Technological SciencesJerome Canady Research Institute for Advanced Biological and Technological SciencesJerome Canady Research Institute for Advanced Biological and Technological SciencesPlasma Medicine Life SciencesJerome Canady Research Institute for Advanced Biological and Technological SciencesJerome Canady Research Institute for Advanced Biological and Technological SciencesJerome Canady Research Institute for Advanced Biological and Technological SciencesAbstract Cholangiocarcinoma (CCA) is a rare biliary tract cancer with a low five-year survival rate and high recurrence rate after surgical resection. Currently treatment approaches include systemic chemotherapeutics such as FOLFIRINOX, a chemotherapy regimen is a possible treatment for severe CCA cases. A limitation of this chemotherapy regimen is its toxicity to patients and adverse events. There exists a need for therapies to alleviate the toxicity of a FOLFIRINOX regimen while enhancing or not altering its anticancer properties. Cold atmospheric plasma (CAP) is a technology with a promising future as a selective cancer treatment. It is critical to know the potential interactions between CAP and adjuvant chemotherapeutics. In this study the aim is to characterize the efficacy of FOLFIRINOX and CAP in combination to understand potential synergetic effect on CCA cells. FOLFIRINOX treatment alone at the highest dose tested (53.8 µM fluorouracil, 13.7 µM Leucovorin, 5.1 µM Irinotecan, and 3.7 µM Oxaliplatin) reduced CCA cell viability to below 20% while CAP treatment alone for 7 min reduced viability to 3% (p < 0.05). An analysis of cell viability, proliferation, and cell cycle demonstrated that CAP in combination with FOLFIRINOX is more effective than either treatment alone at a lower FOLFIRINOX dose of 6.7 µM fluorouracil, 1.7 µM leucovorin, 0.6 µM irinotecan, and 0.5 µM oxaliplatin and a shorter CAP treatment of 1, 3, or 5 min. In conclusion, CAP has the potential to reduce the toxicity burden of FOLFIRINOX and warrants further investigation as an adjuvant therapy.https://doi.org/10.1038/s41598-021-88451-w |
| spellingShingle | Olivia Jones Xiaoqian Cheng Saravana R. K. Murthy Lawan Ly Taisen Zhuang Giacomo Basadonna Michael Keidar Jerome Canady The synergistic effect of Canady Helios cold atmospheric plasma and a FOLFIRINOX regimen for the treatment of cholangiocarcinoma in vitro Scientific Reports |
| title | The synergistic effect of Canady Helios cold atmospheric plasma and a FOLFIRINOX regimen for the treatment of cholangiocarcinoma in vitro |
| title_full | The synergistic effect of Canady Helios cold atmospheric plasma and a FOLFIRINOX regimen for the treatment of cholangiocarcinoma in vitro |
| title_fullStr | The synergistic effect of Canady Helios cold atmospheric plasma and a FOLFIRINOX regimen for the treatment of cholangiocarcinoma in vitro |
| title_full_unstemmed | The synergistic effect of Canady Helios cold atmospheric plasma and a FOLFIRINOX regimen for the treatment of cholangiocarcinoma in vitro |
| title_short | The synergistic effect of Canady Helios cold atmospheric plasma and a FOLFIRINOX regimen for the treatment of cholangiocarcinoma in vitro |
| title_sort | synergistic effect of canady helios cold atmospheric plasma and a folfirinox regimen for the treatment of cholangiocarcinoma in vitro |
| url | https://doi.org/10.1038/s41598-021-88451-w |
| work_keys_str_mv | AT oliviajones thesynergisticeffectofcanadyhelioscoldatmosphericplasmaandafolfirinoxregimenforthetreatmentofcholangiocarcinomainvitro AT xiaoqiancheng thesynergisticeffectofcanadyhelioscoldatmosphericplasmaandafolfirinoxregimenforthetreatmentofcholangiocarcinomainvitro AT saravanarkmurthy thesynergisticeffectofcanadyhelioscoldatmosphericplasmaandafolfirinoxregimenforthetreatmentofcholangiocarcinomainvitro AT lawanly thesynergisticeffectofcanadyhelioscoldatmosphericplasmaandafolfirinoxregimenforthetreatmentofcholangiocarcinomainvitro AT taisenzhuang thesynergisticeffectofcanadyhelioscoldatmosphericplasmaandafolfirinoxregimenforthetreatmentofcholangiocarcinomainvitro AT giacomobasadonna thesynergisticeffectofcanadyhelioscoldatmosphericplasmaandafolfirinoxregimenforthetreatmentofcholangiocarcinomainvitro AT michaelkeidar thesynergisticeffectofcanadyhelioscoldatmosphericplasmaandafolfirinoxregimenforthetreatmentofcholangiocarcinomainvitro AT jeromecanady thesynergisticeffectofcanadyhelioscoldatmosphericplasmaandafolfirinoxregimenforthetreatmentofcholangiocarcinomainvitro AT oliviajones synergisticeffectofcanadyhelioscoldatmosphericplasmaandafolfirinoxregimenforthetreatmentofcholangiocarcinomainvitro AT xiaoqiancheng synergisticeffectofcanadyhelioscoldatmosphericplasmaandafolfirinoxregimenforthetreatmentofcholangiocarcinomainvitro AT saravanarkmurthy synergisticeffectofcanadyhelioscoldatmosphericplasmaandafolfirinoxregimenforthetreatmentofcholangiocarcinomainvitro AT lawanly synergisticeffectofcanadyhelioscoldatmosphericplasmaandafolfirinoxregimenforthetreatmentofcholangiocarcinomainvitro AT taisenzhuang synergisticeffectofcanadyhelioscoldatmosphericplasmaandafolfirinoxregimenforthetreatmentofcholangiocarcinomainvitro AT giacomobasadonna synergisticeffectofcanadyhelioscoldatmosphericplasmaandafolfirinoxregimenforthetreatmentofcholangiocarcinomainvitro AT michaelkeidar synergisticeffectofcanadyhelioscoldatmosphericplasmaandafolfirinoxregimenforthetreatmentofcholangiocarcinomainvitro AT jeromecanady synergisticeffectofcanadyhelioscoldatmosphericplasmaandafolfirinoxregimenforthetreatmentofcholangiocarcinomainvitro |